NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
Back to search
Official data from USPTO
CONCORDIA RX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
05/12/2026
Trademark type
Combined
Nice classes
5
Filing date
05/16/2024
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2017-03-00
First use in commerce
2017-03-00
Drawing code
3
Owner type
99
Owner location
Luxembourg, LU
Examiner
DIBBLE,JENNA M
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording "CONCORDIA", with the prescription symbol "RX" forming the "R" in "CONCORDIA".
Holders and representatives
Holders
Concordia Pharmaceuticals Inc., S.à.r.L
Representatives
Caroline Duncan Baker Botts L.L.P.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
a full line of pharmaceuticals for the treatment of depressionmalariabenign prostatic hyperplasiapartial seizures in adults with epilepsyheart failure in adultsheart failure in pediatric patientsatrial fibrillation in adultsedema associated with congestive heart failureedema associated with cirrhosis of the liveredema associated with nephrotic syndromesteroid-induced edemaidiopathic edemaedema due to secondary hyperaldosteronismirritable bowel syndrome (irritable colonspastic colonmucous colitis)acute enterocolitisduodenal ulcer; anti-inflammatory medicines and immunosuppressive agents (corticosteroids)
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2026
PUBO
PUBLISHED FOR OPPOSITION
03/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/27/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/27/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/27/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/27/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/19/2026
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/10/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2026
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/23/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/23/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/23/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/23/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/27/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/27/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/25/2025
GNRT
NON-FINAL ACTION E-MAILED
07/25/2025
CNRT
NON-FINAL ACTION WRITTEN
07/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
03/18/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
03/18/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2024
GNRT
NON-FINAL ACTION E-MAILED
12/22/2024
CNRT
NON-FINAL ACTION WRITTEN
12/22/2024
DOCK
ASSIGNED TO EXAMINER
12/02/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/18/2024
NWAP
NEW APPLICATION ENTERED
05/16/2024
Continuous trademark protection
Get notified about every new filing that threatens CONCORDIA RX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.